AdFDA-Approved First-Line Treatment Option For Certain Patients With Advanced Kidney Cancer. Learn About This First-Line Treatment Option For Certain Advanced Kidney Cancer Patients.
Types: Side Effects, Clinical Trial Results, Patient Site, Dosing Information
AdLearn About The Now Approved Treatment Option. View The ADRIATIC Study Data. Physicians: View IMFINZI Safety & Trial Results. Read About The Treatment Option.